Table I.
Glycopeptide ID | Compound name | Printed concentration |
---|---|---|
1 | Agalacto glycopeptide | 0.4 mg/mL |
2 | Agalacto glycopeptide | 0.2 mg/mL |
3 | Asialo glycopeptide | 0.4 mg/mL |
4 | Asialo glycopeptide | 0.2 mg/mL |
5 | Sialo glycopeptide | 0.4 mg/mL |
6 | Sialo glycopeptide | 0.2 mg/mL |
7 | Man3 glycopeptide | 0.4 mg/mL |
8 | Man3 glycopeptide | 0.2 mg/mL |
9 | Core xylose/core fucose glycopeptide | 0.4 mg/mL |
10 | Core xylose/core fucose glycopeptide | 0.2 mg/mL |
11 | Core xylose glycopeptide | 0.4 mg/mL |
12 | Core xylose glycopeptide | 0.2 mg/mL |
13 | LDN glycopeptide | 0.4 mg/mL |
14 | LDN glycopeptide | 0.2 mg/mL |
15 | LDNF glycopeptide | 0.4 mg/mL |
16 | LDNF glycopeptide | 0.2 mg/mL |
17 | Lewis a (Lea) glycan | 100 µM |
18 | Lewis x (LeX) glycan | 100 µM |
19 | PBS | |
20 | Biotin | |
21 | Core fucose (Fuc-Man3) glycopeptide | 0.4 mg/mL |
22 | Core fucose (Fuc-Man3) glycopeptide | 0.2 mg/ml |
23 | Asialo glycan-AEAB | 100 μM |
24 | Man5 glycan-AEAB | 100 μM |
Structures 1–16 and 21–24 are symmetrical biantennary structures. 21–24 were added on a second iteration of the array. See Figure 1 for the structural details.